Although the precise roles of MCT1/4 in the pyruvate transport of cancer cells need further investigation, these conflicting results proposed alternative molecular mechanisms for the action of MCT inhibitors in addition to their effects on lactate transport. Here, SLC16A1 is linked to cancer.